Marksans Pharma Limited — Board Meeting, 25-07-2025: Outcome of Board Meeting

Marksans Pharma's board has re-appointed Mr. Mark Saldanha as Managing Director for a further five-year term, effective October 6, 2025. This crucial re-appointment awaits shareholder approval at the upcoming Annual General Meeting. Mr. Saldanha, with over 24 years of diverse experience, is lauded as the principal architect of the company's progress and success, steering its rapid growth and higher performance through his dynamic leadership.